发明名称 INDUCIBLE EUKARYOTIC EXPRESSION SYSTEM
摘要 <p><P>PROBLEM TO BE SOLVED: To provide a tightly regulated inducible eukaryotic expression system suitable for large scale production of a recombinant molecule of interest in an eukaryotic cell. <P>SOLUTION: Compositions and methods for the inducible expression of genes in eukaryotic cells are provided. Expression of a nucleotide sequence of interest is controlled by a regulatory fusion protein that consists of a transcription blocking domain and a ligand-binding domain. When the cognate ligand for the ligand-binding domain is present, transcription of the nucleotide sequence of interest is blocked. Upon removal of the cognate ligand, the nucleotide sequence of interest is transcribed. The method is useful for large scale production of a desired product in eukaryotic cells. <P>COPYRIGHT: (C)2011,JPO&INPIT</p>
申请公布号 JP2011152152(A) 申请公布日期 2011.08.11
申请号 JP20110110860 申请日期 2011.05.17
申请人 REGENERON PHARMACEUTICALS INC 发明人 FANDL JAMES P;DOU CHANGLIN
分类号 A01K67/027;C12N15/09;C07K19/00;C12N1/15;C12N1/19;C12N5/10;C12N15/63;C12N15/85;C12P21/00 主分类号 A01K67/027
代理机构 代理人
主权项
地址